Total Events and Net Clinical Benefit of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: The COMPASS Trial
American Heart Journal（2023）
摘要
NCT01776424. https://clinicaltrials.gov/ct2/show/NCT01776424.
更多查看译文
关键词
COMPASS clinical trial,Chronic coronary artery disease,Peripheral arterial disease,Recurrent events,Rivaroxaban
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要